Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma

Immune checkpoint inhibitors blocking the interaction between programmed death-1 (PD-1) and PD-1 ligand-1 (PD-L1) are revolutionizing the cancer immunotherapies with durable clinical responses. Although high expression of PD-L1 in tumor tissues has been implicated to correlate with the better respon...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncoimmunology
मुख्य लेखकों: Inoue, Hiroyuki, Park, Jae-Hyun, Kiyotani, Kazuma, Zewde, Makda, Miyashita, Azusa, Jinnin, Masatoshi, Kiniwa, Yukiko, Okuyama, Ryuhei, Tanaka, Ryota, Fujisawa, Yasuhiro, Kato, Hiroshi, Morita, Akimichi, Asai, Jun, Katoh, Norito, Yokota, Kenji, Akiyama, Masashi, Ihn, Hironobu, Fukushima, Satoshi, Nakamura, Yusuke
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis 2016
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5048759/
https://ncbi.nlm.nih.gov/pubmed/27757299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1204507
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन